drugset / Trial / NCT02326090
Phase 2 Study With Cis-UCA Ophthalmic Solutions in Subjects With Dry Eye
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of the Phase 2 study is to compare the safety and efficacy of cis-UCA Ophthalmic Solutions to placebo for the treatment of the signs and symptoms of dry eye.
Timeline
- Start
- 2014-12
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cis-UCA | Unknown | 1 % | Other |
| Comparator | Cis-UCA | Unknown | 2.5 % | Other |